| Immunovative 2010 news release |
|
Immunovative announces today that it has been awarded a matching fund grant by the Israel Office of the Chief Scientist in the amount of NIS4.5 million. The actual funds awarded to the Company is approximately US$600,000 this year. These funds help support our research and development activities in Israel.
The United States Patent Office has issued a Notice of Allowance for patent application entitled: METHODS FOR PREPARING T-CELLS FOR CELL THERAPY.
More News..
|